| Product Code: ETC9967918 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) IVD Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) IVD Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) IVD Market - Industry Life Cycle |
3.4 United States (US) IVD Market - Porter's Five Forces |
3.5 United States (US) IVD Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) IVD Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 United States (US) IVD Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) IVD Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) IVD Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the US |
4.2.2 Technological advancements in the field of in vitro diagnostics (IVD) |
4.2.3 Growing demand for personalized medicine in the healthcare sector |
4.2.4 Rising geriatric population leading to higher healthcare needs |
4.2.5 Favorable government initiatives and regulations supporting the IVD market growth |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approvals |
4.3.2 High initial costs associated with acquiring and maintaining IVD equipment |
4.3.3 Lack of skilled professionals in the IVD industry |
4.3.4 Reimbursement challenges for IVD tests and services |
4.3.5 Data privacy and security concerns related to IVD technologies |
5 United States (US) IVD Market Trends |
6 United States (US) IVD Market, By Types |
6.1 United States (US) IVD Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) IVD Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) IVD Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 United States (US) IVD Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) IVD Market Revenues & Volume, By Software And Services, 2021- 2031F |
6.2 United States (US) IVD Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 United States (US) IVD Market Revenues & Volume, By Immunodiagnostics, 2021- 2031F |
6.2.3 United States (US) IVD Market Revenues & Volume, By Blood Testing, 2021- 2031F |
6.2.4 United States (US) IVD Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.5 United States (US) IVD Market Revenues & Volume, By Tissue Diagnostics, 2021- 2031F |
6.2.6 United States (US) IVD Market Revenues & Volume, By Clinical Chemistry, 2021- 2031F |
6.2.7 United States (US) IVD Market Revenues & Volume, By Other Ivd Techniques, 2021- 2031F |
6.3 United States (US) IVD Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) IVD Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.3 United States (US) IVD Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 United States (US) IVD Market Revenues & Volume, By Cardiac Diseases, 2021- 2031F |
6.3.5 United States (US) IVD Market Revenues & Volume, By Immune System Disorders, 2021- 2031F |
6.3.6 United States (US) IVD Market Revenues & Volume, By Nephrological Diseases, 2021- 2031F |
6.3.7 United States (US) IVD Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.4 United States (US) IVD Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) IVD Market Revenues & Volume, By Standalone Laboratories, 2021- 2031F |
6.4.3 United States (US) IVD Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 United States (US) IVD Market Revenues & Volume, By Academic And Medical Schools, 2021- 2031F |
6.4.5 United States (US) IVD Market Revenues & Volume, By Point Of Care Testing, 2021- 2031F |
6.4.6 United States (US) IVD Market Revenues & Volume, By Others End-User, 2021- 2031F |
7 United States (US) IVD Market Import-Export Trade Statistics |
7.1 United States (US) IVD Market Export to Major Countries |
7.2 United States (US) IVD Market Imports from Major Countries |
8 United States (US) IVD Market Key Performance Indicators |
8.1 Adoption rate of next-generation sequencing (NGS) technologies in the US IVD market |
8.2 Percentage of healthcare facilities using point-of-care testing (POCT) devices |
8.3 Rate of integration of artificial intelligence (AI) solutions in IVD processes |
8.4 Number of research partnerships between industry players and academic institutions focused on IVD innovation |
8.5 Patient satisfaction levels with the accuracy and timeliness of IVD test results |
9 United States (US) IVD Market - Opportunity Assessment |
9.1 United States (US) IVD Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) IVD Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 United States (US) IVD Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) IVD Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) IVD Market - Competitive Landscape |
10.1 United States (US) IVD Market Revenue Share, By Companies, 2024 |
10.2 United States (US) IVD Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here